DK0437025T3 - Midler indeholdende aldosereduktaseinhibitorer til behandling af ulcera - Google Patents

Midler indeholdende aldosereduktaseinhibitorer til behandling af ulcera

Info

Publication number
DK0437025T3
DK0437025T3 DK90312053.3T DK90312053T DK0437025T3 DK 0437025 T3 DK0437025 T3 DK 0437025T3 DK 90312053 T DK90312053 T DK 90312053T DK 0437025 T3 DK0437025 T3 DK 0437025T3
Authority
DK
Denmark
Prior art keywords
treatment
aldose reductase
ulcers
reductase inhibitors
agents containing
Prior art date
Application number
DK90312053.3T
Other languages
English (en)
Inventor
Kiichi Sawai
Masayasu Kuroni
Kazumasa Nakano
Makoto Sato
Noboru Kuboyama
Takashi Ito
Yoshiya Kondo
Original Assignee
Sanwa Kagaku Kenkyusho Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanwa Kagaku Kenkyusho Co filed Critical Sanwa Kagaku Kenkyusho Co
Application granted granted Critical
Publication of DK0437025T3 publication Critical patent/DK0437025T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK90312053.3T 1990-01-12 1990-11-02 Midler indeholdende aldosereduktaseinhibitorer til behandling af ulcera DK0437025T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005773A JPH03215435A (ja) 1990-01-12 1990-01-12 アルドース還元酵素阻害剤を主成分とする潰瘍治療剤

Publications (1)

Publication Number Publication Date
DK0437025T3 true DK0437025T3 (da) 1995-12-18

Family

ID=11620439

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90312053.3T DK0437025T3 (da) 1990-01-12 1990-11-02 Midler indeholdende aldosereduktaseinhibitorer til behandling af ulcera

Country Status (7)

Country Link
US (1) US5155125A (da)
EP (1) EP0437025B1 (da)
JP (1) JPH03215435A (da)
AT (1) ATE127344T1 (da)
DE (1) DE69022206T2 (da)
DK (1) DK0437025T3 (da)
ES (1) ES2078319T3 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0661293A3 (en) * 1993-12-29 1999-05-19 Sanwa Kagaku Kenkyusho Co., Ltd. Protein having cell growth-stimulating and macrophage chemotactic actions, preparative method therefor and use thereof
DE69519219T2 (de) * 1994-12-28 2001-02-22 Sanwa Kagaku Kenkyusho Co Verwendung von (2S,4S)-6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazoline]-2-carboxamid zur Behandlung von Keratopathie
EP0909558A3 (en) * 1997-08-29 1999-10-27 Santen Pharmaceutical Co., Ltd. Chroman derivative containing ophthalmic solution
WO2006022450A1 (ja) * 2004-08-26 2006-03-02 Santen Pharmaceutical Co., Ltd. 皮膚疾患治療剤
CA2685202C (en) 2007-03-23 2017-11-28 The Board Of Regents Of The University Of Texas System Methods for treating allergic asthma
AU2011348074B2 (en) * 2010-12-23 2016-04-28 The Board Of Regents Of The University Of Texas System Methods for treating COPD

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4147795A (en) * 1977-02-11 1979-04-03 Pfizer Inc. Hydantoin derivatives as therapeutic agents
EP0006352A1 (en) * 1978-06-15 1980-01-09 Beecham Group Plc Hydantoins and thiohydantoins, process for their preparation and pharmaceutical compositions containing them
CH638975A5 (fr) * 1979-07-27 1983-10-31 Prebuilt Ets Composition medicamenteuse pour le traitement des ulceres gastro-duodenaux.
US4248882A (en) * 1980-02-12 1981-02-03 Pfizer Inc. Treating diabetes-associated complications with hydantoin amines
US4600717A (en) * 1984-04-11 1986-07-15 Alcon Laboratories, Inc. Aldose reductase inhibitors useful in ophthalmic wound healing
US4717725A (en) * 1984-04-11 1988-01-05 Alcon Laboratories, Inc. Ophthalmic wound healing with aldose reductase inhibitors
EP0264586B1 (en) * 1986-08-28 1991-04-03 Sanwa Kagaku Kenkyusho Co., Ltd. Hydantoin derivatives for treating complications of diabetes
ATE96668T1 (de) * 1989-02-22 1993-11-15 Sanwa Kagaku Kenkyusho Co Pharmazeutische zusammensetzung, die ein hydantoin-derivat enthaelt.

Also Published As

Publication number Publication date
ES2078319T3 (es) 1995-12-16
JPH03215435A (ja) 1991-09-20
ATE127344T1 (de) 1995-09-15
DE69022206T2 (de) 1996-04-18
EP0437025A2 (en) 1991-07-17
DE69022206D1 (de) 1995-10-12
EP0437025B1 (en) 1995-09-06
US5155125A (en) 1992-10-13
EP0437025A3 (en) 1992-02-26

Similar Documents

Publication Publication Date Title
AU549481B2 (en) Hair growing agent
ATE157005T1 (de) Verwendung von sertindol zur behandlung von schizophrenie
CA2312935A1 (en) Hydroxamic acid derivatives as matrix metalloprotease (mmp) inhibitors
FI925787A0 (fi) Proteolytiska enzymers sackarinderivatinhibitorer
ATE232862T1 (de) Oxazolidinon derivate und diese enthaltende pharmazeutische zusammensetzungen
DE69732170D1 (de) Formulierung mit verzögerter Freisetzung enthaltend Kollagen und Glykosaminoglykan
TR200000129T2 (tr) Yepyeni spiroazabisiklik heterosiklik bileşikler.
NO890259L (no) Fremgangsmaate for fremstilling av terapeutisk aktive etylfenoksyacetamider.
DK0437025T3 (da) Midler indeholdende aldosereduktaseinhibitorer til behandling af ulcera
NO980793D0 (no) Anvendelse av aminoadamantanforbindelse som immunregulatorer
DK0617959T3 (da) Lægemiddel til behandling af hudsygdomme
NO971743L (no) Farmasöytisk sammensetning for profylakse og behandling av type I allergiske sykdommer
ATE75399T1 (de) Therapeutikum zur behandlung von magengeschwueren.
ATE103587T1 (de) N-alkyl-n-(meth)acryloyloxyalkylcarboxamide aromatischer carbonsaeuren und aromatischer carbonsaeureanhydride sowie adhaesive enthaltend diese verbindungen.
SE0004827D0 (sv) Therapeutic compounds
NO984651L (no) Anvendelse av benzonaftalenderivater for fremstilling av medikamenter for behandling av sykdommer i sentralnervesystemet
ATE247903T1 (de) Fungizide zusammensetzung enthaltend ein n- benzoyl-n'-phenyl-harnstoff derivat
ATE71091T1 (de) Tetrahydro-1,2,4-oxadiazin-5-thion-derivate.